Tobias S, Bird J, Guzman SM, Palis H, Crabtree A, Hein JE, Wood E, Ti L Temporal and regional associations between fentanyl concentrations in the unregulated drug supply and drug-related mortality in British Columbia, Canada Int J Drug Policy PubMed
Tobias S, Grant C, Lysyshyn M, Roux P, Wood E, Kerr T, Ti L Risk reduction behaviours following the detection of unexpected drugs through community drug checking: a cross-sectional study Harm Reduct J PubMed
Tobias S, Guzman SM, Hein JE, Ti L Development and validation of a fentanyl quantification model for drug checking services Drug Alcohol Depend Rep PubMed
Airth L, Goodyear T, Marshall BDL, Grant C, Lysyshyn M, Sherman SG, Wood E, Ti L Unintentional benzodiazepine use and frequency of drug checking service utilization: a cross-sectional study Harm Reduct J PubMed
Tobias S, Tu A, Shapiro AM, Mérette SAM, Lysyshyn M, Wood E, Buxton JA, Ti L Fentanyl concentrations in unregulated opioids and the blood of drug toxicity decedents AJE Adv Link
Bird J, Tobias S, Grant C, Lysyshyn M, Tupper K, Wood E, Kerr T, Ti L Sharing drug checking results in a Canadian setting: a multi-site analysis Int J Drug Policy PubMed
Esopenko H, Marshall BDL, Lysyshyn M, Grant C, Sherman SG, Wood E, Kerr T, Ti L Impact of having a regular drug dealer on obtaining drug checking results consistent with expectations during a drug toxicity crisis in a Canadian setting Drug Alcohol Depend PubMed
Crepeault H, Tobias S, Angelucci J, Dubland S, Lysyshyn M, Wood E, Ti L Detection of benzodiazepines in the unregulated drug supply using point of care and confirmatory drug checking technologies: a validation study Drug Alcohol Depend PubMed
Tobias S, Angelucci J, Wood E, Buxton JA, Ti L Novel adulterants in unregulated opioids and their associations with adverse events Can J Public Health PubMed
